rs149733287

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PVS1_ModerateBP6BS1BS2

The NM_018127.7(ELAC2):​c.560-2A>G variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000468 in 1,614,178 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0026 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 2 hom. )

Consequence

ELAC2
NM_018127.7 splice_acceptor, intron

Scores

1
3
2
Splicing: ADA: 1.000
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 3.04

Publications

3 publications found
Variant links:
Genes affected
ELAC2 (HGNC:14198): (elaC ribonuclease Z 2) The protein encoded by this gene has a C-terminal domain with tRNA 3′ processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
ELAC2 Gene-Disease associations (from GenCC):
  • combined oxidative phosphorylation defect type 17
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.048367593 fraction of the gene. Cryptic splice site detected, with MaxEntScore 4.3, offset of -31, new splice context is: tgtcagctcaccttgtgcAGtgt. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
BP6
Variant 17-13011784-T-C is Benign according to our data. Variant chr17-13011784-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 235643.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00257 (391/152290) while in subpopulation AFR AF = 0.00876 (364/41560). AF 95% confidence interval is 0.00802. There are 3 homozygotes in GnomAd4. There are 187 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018127.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ELAC2
NM_018127.7
MANE Select
c.560-2A>G
splice_acceptor intron
N/ANP_060597.4
ELAC2
NM_173717.2
c.560-2A>G
splice_acceptor intron
N/ANP_776065.1
ELAC2
NM_001165962.2
c.560-1113A>G
intron
N/ANP_001159434.1Q9BQ52-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ELAC2
ENST00000338034.9
TSL:1 MANE Select
c.560-2A>G
splice_acceptor intron
N/AENSP00000337445.4Q9BQ52-1
ELAC2
ENST00000923774.1
c.662-2A>G
splice_acceptor intron
N/AENSP00000593833.1
ELAC2
ENST00000860253.1
c.560-2A>G
splice_acceptor intron
N/AENSP00000530312.1

Frequencies

GnomAD3 genomes
AF:
0.00258
AC:
392
AN:
152172
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00881
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000696
AC:
175
AN:
251456
AF XY:
0.000552
show subpopulations
Gnomad AFR exome
AF:
0.0103
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000249
AC:
364
AN:
1461888
Hom.:
2
Cov.:
33
AF XY:
0.000204
AC XY:
148
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.00962
AC:
322
AN:
33480
American (AMR)
AF:
0.000224
AC:
10
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1112010
Other (OTH)
AF:
0.000464
AC:
28
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00257
AC:
391
AN:
152290
Hom.:
3
Cov.:
32
AF XY:
0.00251
AC XY:
187
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00876
AC:
364
AN:
41560
American (AMR)
AF:
0.00144
AC:
22
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68024
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000817
Hom.:
2
Bravo
AF:
0.00286
ESP6500AA
AF:
0.00681
AC:
30
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000832
AC:
101
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
1
Combined oxidative phosphorylation defect type 17 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
-0.080
CADD
Uncertain
25
DANN
Benign
0.96
Eigen
Pathogenic
0.82
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.91
D
PhyloP100
3.0
GERP RS
4.4
PromoterAI
0.011
Neutral
Mutation Taster
=65/35
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.79
SpliceAI score (max)
0.69
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.69
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149733287; hg19: chr17-12915101; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.